Clinical Trial

PreOperative Endocrine Therapy for Individualised Care With Abemaciclib

Study acronym: POETIC-A
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
POETIC-A is a phase 3 trial which targets post-menopausal primary breast cancer patients with a high 5-year risk of relapse as determined by a high Ki67 after 2 weeks aromatase inhibitor therapy pre-surgery. Eligible patients will be randomised to standard adjuvant endocrine therapy alone or standard adjuvant endocrine therapy with a CDK4/6 inhibitor called abemaciclib.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2020-10-12; most recent amendment 2026-01-13.
Status change: Recruiting → Active, Not Recruiting 2026-01-13
Status change: Not Yet Recruiting → Recruiting 2021-06-16
Trial Details
NCT Number NCT04584853
Lead Sponsor Institute of Cancer Research, United Kingdom
Conditions Breast Cancer Female
Enrollment 123 participants
Start Date 2020-12-23
Primary Completion 2030-10 (estimated)
Study Completion 2030-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-14